How would anyone know how to value even after approval? What are we paying Advent. Are we merging the two entities. What will we charge per patient or dose? Will someone like Walgreens be distributing kits to store and ship the tumor and/or for the lysate?
They do not tell you enough to make a decision for valuation. I can only say as an all solid tumor vaccine we are probably way too cheap now.
Market Data 
Markets 
AI
